Clinical Trial Update: SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

This update describes an ongoing Phase 4 trial evaluating the safety and efficacy of SGLT2 inhibitors on kidney allograft function in non-diabetic kidney transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Odense University Hospital | Conditions: Kidney Transplantation Recipients, Sodium-Glucose Transporter 2 Inhibitors | Phase 4 | Status: RECRUITING